Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathan Fowler

Showing results (21-30 of 87) with videos related to

Pageof 9
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2010
Benefit of consolidative radiation therapy in patients with diffuse large B-cell lymphoma treated with R-CHOP chemotherapyJack Phan, Ali Mazloom, L Jeffrey Medeiros, et al.
Cancer Cell|May 21, 2021
Conserved pan-cancer microenvironment subtypes predict response to immunotherapyAlexander Bagaev, Nikita Kotlov, Krystle Nomie, et al.
Ophthalmic Plastic and Reconstructive Surgery|August 21, 2018
Prevalence of a Histologic Change of Ocular Adnexal Lymphoma in Patients With a History of LymphomaOded Sagiv, Sudip D Thakar, John T Manning, et al.
British Journal of Haematology|May 23, 2018
Four-year follow-up of a single arm, phase II clinical trial of ibrutinib with rituximab (IR) in patients with relapsed/refractory mantle cell lymphoma (MCL)Preetesh Jain, Jorge Romaguera, Samer A Srour, et al.
Leukemia & Lymphoma|April 11, 2015
Primary cutaneous B-cell lymphoma (non-leg type) has excellent outcomes even after very low dose radiation as single-modality therapyMani Akhtari, Jay Paul Reddy, Chelsea C Pinnix, et al.
Nature Reviews. Clinical Oncology|December 30, 2016
The landscape of new drugs in lymphomaAnas Younes, Stephen Ansell, Nathan Fowler, et al.
Leukemia & Lymphoma|September 20, 2019
<i>De novo</i> CD5+ diffuse large B-cell lymphoma, NOS: clinical characteristics and outcomes in rituximab eraBei Hu, Loretta J Nastoupil, Sanam Loghavi, et al.
Journal of the National Cancer Institute|January 2, 2017
Recommendations for Clinical Trial Development in Follicular LymphomaKami Maddocks, Paul M Barr, Bruce D Cheson, et al.
British Journal of Haematology|January 7, 2014
The prognostic value of interim positron emission tomography scan in patients with classical Hodgkin lymphomaYasuhiro Oki, Hubert Chuang, Beth Chasen, et al.
International Journal of Radiation Oncology, Biology, Physics|February 16, 2019
Outcomes After Reduced-Dose Intensity Modulated Radiation Therapy for Gastric Mucosa-Associated Lymphoid Tissue (MALT) LymphomaChelsea C Pinnix, Jillian R Gunther, Sarah A Milgrom, et al.
Pageof 9

Showing results (21-30 of 87) with videos related to

Sort By:
Pageof 9
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2010
Benefit of consolidative radiation therapy in patients with diffuse large B-cell lymphoma treated with R-CHOP chemotherapyJack Phan, Ali Mazloom, L Jeffrey Medeiros, et al.
Cancer Cell|May 21, 2021
Conserved pan-cancer microenvironment subtypes predict response to immunotherapyAlexander Bagaev, Nikita Kotlov, Krystle Nomie, et al.
Ophthalmic Plastic and Reconstructive Surgery|August 21, 2018
Prevalence of a Histologic Change of Ocular Adnexal Lymphoma in Patients With a History of LymphomaOded Sagiv, Sudip D Thakar, John T Manning, et al.
British Journal of Haematology|May 23, 2018
Four-year follow-up of a single arm, phase II clinical trial of ibrutinib with rituximab (IR) in patients with relapsed/refractory mantle cell lymphoma (MCL)Preetesh Jain, Jorge Romaguera, Samer A Srour, et al.
Leukemia & Lymphoma|April 11, 2015
Primary cutaneous B-cell lymphoma (non-leg type) has excellent outcomes even after very low dose radiation as single-modality therapyMani Akhtari, Jay Paul Reddy, Chelsea C Pinnix, et al.
Nature Reviews. Clinical Oncology|December 30, 2016
The landscape of new drugs in lymphomaAnas Younes, Stephen Ansell, Nathan Fowler, et al.
Leukemia & Lymphoma|September 20, 2019
<i>De novo</i> CD5+ diffuse large B-cell lymphoma, NOS: clinical characteristics and outcomes in rituximab eraBei Hu, Loretta J Nastoupil, Sanam Loghavi, et al.
Journal of the National Cancer Institute|January 2, 2017
Recommendations for Clinical Trial Development in Follicular LymphomaKami Maddocks, Paul M Barr, Bruce D Cheson, et al.
British Journal of Haematology|January 7, 2014
The prognostic value of interim positron emission tomography scan in patients with classical Hodgkin lymphomaYasuhiro Oki, Hubert Chuang, Beth Chasen, et al.
International Journal of Radiation Oncology, Biology, Physics|February 16, 2019
Outcomes After Reduced-Dose Intensity Modulated Radiation Therapy for Gastric Mucosa-Associated Lymphoid Tissue (MALT) LymphomaChelsea C Pinnix, Jillian R Gunther, Sarah A Milgrom, et al.
Pageof 9